Levothyroxine sodium and Light chain analysis increased - a phase IV clinical study of FDA data

Summary:

Light chain analysis increased is reported as a side effect among people who take Levothyroxine sodium (levothyroxine sodium), especially for people who are male, 60+ old, also take Velcade, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Light chain analysis increased when taking Levothyroxine sodium. It is created by eHealthMe based on reports of 122,907 people who have side effects when taking Levothyroxine sodium from the FDA, and is updated regularly.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,813 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.

What is Light chain analysis increased?

Light chain analysis increased is found to be associated with 197 drugs and 149 conditions by eHealthMe. Check the latest studies of Light chain analysis increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

122,907 people reported to have side effects when taking Levothyroxine sodium.
Among them, 14 people (0.01%) have Light chain analysis increased.

Could Levothyroxine sodium cause Light chain analysis increased?

Among these 14 people:

What is the gender of people who have Light chain analysis increased when taking Levothyroxine sodium? *

female: 50 %
male: 50 %

What is the age of people who have Light chain analysis increased when taking Levothyroxine sodium? *

What are other drugs people take besides Levothyroxine sodium? *

What are other side effects people have besides Light chain analysis increased? *

Blood Immunoglobulin G Increased: 4 people, 28.57%
Thrombocytopenia (decrease of platelets in blood): 4 people, 28.57%
Dyspnea (difficult or laboured breathing): 4 people, 28.57%
Haemoglobin Decreased: 3 people, 21.43%
Insomnia (sleeplessness): 3 people, 21.43%
Pain: 3 people, 21.43%
Nausea (feeling of having an urge to vomit): 3 people, 21.43%
Anaemia (lack of blood): 3 people, 21.43%
Acute Kidney Failure: 3 people, 21.43%
Dizziness: 3 people, 21.43%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 71.43%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%
Metastases To Bone (cancer spreads to bone): 2 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
Urinary Tract Infection: 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Constipation: 1 person, 7.14%
Cardiac Disorder: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Levothyroxine sodium and have Light chain analysis increased?

- Check whether Light chain analysis increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levothyroxine sodium:

Levothyroxine sodium (129,813 reports)

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Light chain analysis increased:

Light chain analysis increased (197 drugs)

Browse all the conditions that are associated with Light chain analysis increased:

Light chain analysis increased (149 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Levothyroxine sodium) and Levothyroxine sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.